Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$83.7K Sell
64,373
-24,696
-28% -$34K ﹤0.01% 12610
2026
Q1
$115K Sell
89,069
-100,371
-53% -$166K ﹤0.01% 12240
2025
Q4
$419K Buy
189,440
+121,646
+179% +$229K ﹤0.01% 9203
2025
Q3
$110K Buy
67,794
+17,484
+35% +$36.6K ﹤0.01% 11507
2025
Q2
$130K Sell
50,310
-5,920
-11% -$23.4K ﹤0.01% 11609
2025
Q1
$378K Buy
56,230
+29,945
+114% +$212K ﹤0.01% 9537
2024
Q4
$178K Sell
26,285
-18,311
-41% -$121K ﹤0.01% 10847
2024
Q3
$370K Buy
44,596
+13,787
+45% +$99.8K ﹤0.01% 9153
2024
Q2
$195K Sell
30,809
-31,081
-50% -$239K ﹤0.01% 10384
2024
Q1
$574K Buy
61,890
+43,975
+245% +$516K ﹤0.01% 8177
2023
Q4
$228K Sell
17,915
-37,308
-68% -$389K ﹤0.01% 10402
2023
Q3
$570K Sell
55,223
-27,105
-33% -$314K ﹤0.01% 7914
2023
Q2
$1.08M Buy
82,328
+14,472
+21% +$177K ﹤0.01% 6506
2023
Q1
$759K Buy
67,856
+11,869
+21% +$117K ﹤0.01% 7523
2022
Q4
$472K Buy
55,987
+40,231
+255% +$383K ﹤0.01% 8019
2022
Q3
$262K Sell
15,756
-84,913
-84% -$1.56M ﹤0.01% 10140
2022
Q2
$1.48M Sell
100,669
-81,259
-45% -$1.67M ﹤0.01% 5560
2022
Q1
$4.51M Buy
+181,928
New +$4.7M ﹤0.01% 3805

Other funds holding LUNG

Jeff Yass's LUNG Position: Q2 2026 in Review

Jeff Yass reduced its Pulmonx (LUNG) stake by 28% in Q2 2026, selling an estimated $34K and leaving 64,373 shares worth $83.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12610.

Jeff Yass first reported a position in LUNG in Q1 2022 and has held it in 18 quarters since. The position peaked at $4.51M in Q1 2022. 108 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Jeff Yass held 64,373 shares of Pulmonx worth $83.7K as of Q2 2026.
  • Jeff Yass sold 24,696 Pulmonx shares in Q2 2026, an estimated $34K.
  • Pulmonx made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #12610 holding.
  • Jeff Yass first reported a position in Pulmonx in Q1 2022 and has held it in 18 quarters since.
  • Jeff Yass's Pulmonx position peaked at $4.51M in Q1 2022.
  • 108 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.